According the analysts past year's revenue will be around 2,68 billion euros. This is slightly more than the 2014's revenue of 2,57 billion euros. For 2015 most of the analysts expect a net profit of 78,87 million euros.
For 2015 the consensus of the earnings per share of Sligro is at profit of 1,85 euros. With this the PE equals 16,86.
Per share the analysts expact a dividend of 1,21 euros. Consequently the dividend return is around 3,88 percent. On average the stocks in this sector yield a dividend return of around 0,91 percent.
The matrix above shows Sligro's historical returns expressed in the different entry years in the left axis.The year 2009 was with a price loss of 44 percent the worst year investors. 2010 was with a return of 61 percent by far the best year since 2008. Who bought the share in 2008 (price at that time 26,80 euros) now has a price gain of 16 percent.
The stock now trades at 31,20 euros. This equals 20 times the 2014's earnings per share.
The graph above shows the developments of Sligro's stock price (blue) and revenue (red) for the period 2008 till 2015 (the analyst's expectations. It seems that the food & drug retailer's revenue hardly is connected with the stock price: the correlation equals -0,47.
Sligro's book value/price equals 0,42. The food & drug retailer now trades with a CAPE (Shiller PE) of 12.12. The stock now trades at 31,20 euros. This equals 20 times the 2014's earnings per share.
The Sligro stock is covered by 6 analysts (based on fundamental analysis). The average target price for Sligro is at 37,79 euros. This is 20,9 percent more than the current stock price of 31,20 euros. Within the sector food & drug sector the analystst mostly prefer Sligro, Whole Foods Market and Delhaize.
The three most recent recommendations for the food & drug sector were provided by Kepler Capital Markets (hold, 34,00 euros), ING (hold, 36,00 euros) and SNS Securities (buy, 39,76 euros).